Purchase two of the
following online courses in one transaction and save
10%. Purchase all three in one transaction and save
20%. Discount will be reflected in the final step of the
checkout process.
In 90 minutes, you will get a
combination of background instruction into the principals of CER, current
and future impact on the broader regulatory industry, along with
implications for future communications, marketing, monitoring, and
resource planning. Real-world examples will be used to help explain
changing implications of new sources of data and outcomes measures,
detailing the transition to newer CER based advertising and promotional
material and how to effectively incorporate these into developing corporate
sales and marketing, value research, and product attribute messaging.
Faculty:
Danny A. Benau,
PhD, Director, Biomedical Writing Programs, University of
the Sciences
Darshan Kulkarni,
JD, PharmD, MS, Principal Attorney, The Kulkarni Law Firm
Andrew M.
Peterson, PharmD, PhD, Dean, Mayes College, University of
the Sciences
Understand changes to today’s
practices, when and why they are being transitioned to the newer CER
format, and methods to effectively include these changes into future
studies, payor and patient interactions and value focused research.
Faculty:
Danny A. Benau,
PhD, Director, Biomedical Writing Programs, University of
the Sciences
Stephanie Michelle
Knight, Associate Director, Pfizer Inc.
Andrew M.
Peterson, PharmD, PhD, Dean, Mayes College, University of
the Sciences
This 90-minute online offering will
allow you to quickly understand current practices, when and why they are
being transitioned to the newer CER format, and methods to effectively
include these changes into your future investigations.
Faculty:
Danny A. Benau,
PhD, Director, Biomedical Writing Programs, University of
the Sciences
Darshan Kulkarni,
JD, PharmD, MS, Principal Attorney, The Kulkarni Law Firm
Newly Released Webinar:
All transfers of value to covered
recipients must be tracked by covered manufacturers starting August 1.
This 90-minute webinar will provide a high-level overview of the basic
requirements of the final rule for implementing the Physicians Payment
Sunshine Act, before turning to many of the gray areas where
manufacturers are struggling to understand what they need to track and
report. This webinar will focus on the requirements for research-related
activities, indirect payments, and the determination of value for many
educational efforts. Industry experts will help you go beyond a cursory
understanding of the rule to help their organizations determine how they
will ensure compliance and avoid the costly fines.
|
|
|
April 9, 11,
16 & 18
12:00-1:30PM ET
|
April 10
12:00-1:30PM ET
|
April 25-26
10:00-11:30AM ET
|
|
No comments:
Post a Comment